ISO 11137-1:2006
|
Sterilization of health care products Radiation Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices |
ASTM F 2150 : 2013 : REDLINE
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2312 : 2011 : REDLINE
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2211 : 2002
|
Standard Classification for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2150 : 2019
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Regenerative Medicine and Tissue-Engineered Medical Products |
ASTM F 2382 : 2004 : R2010
|
Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT) |
ASTM F 2312 : 2004
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2212 : 2011
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ISO 11135:2014
|
Sterilization of health-care products Ethylene oxide Requirements for the development, validation and routine control of a sterilization process for medical devices |
ASTM F 2739 : 2019
|
Standard Guide for Quantifying Cell Viability and Related Attributes within Biomaterial Scaffolds |
ASTM F 2382 : 2004 : EDT 1
|
Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT) |
ISO 7198:2016
|
Cardiovascular implants and extracorporeal systems — Vascular prostheses — Tubular vascular grafts and vascular patches |
ASTM F 2212 : 2011 : REDLINE
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2382 : 2017
|
Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT) |
ASTM F 1635 : 2016
|
Standard Test Method for in vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2739 : 2008
|
Standard Guide for Quantitating Cell Viability Within Biomaterial Scaffolds |
ASTM F 2212 : 2002 : R2007 : EDT 1
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
CFR 21(PTS800-1299) : 0
|
FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 800-1299 |
ASTM F 2212 : 2019
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2211 : 2013 : R2021
|
Standard Classification for Tissue-Engineered Medical Products (TEMPs) |
ASTM F 2212 : 2002
|
Standard Guide for Characterization of Type I Collagen as a Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2312 : 2011
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 1635 : 2016 : REDLINE
|
Standard Test Method for in vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ISO 22442-1:2015
|
Medical devices utilizing animal tissues and their derivatives Part 1: Application of risk management |
ASTM F 2210 : 2002 : R2010
|
Standard Guide for Processing Cells, Tissues, and Organs for Use in Tissue Engineered Medical Products (Withdrawn 2015) |
ASTM F 2150 : 2013
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2150 : 2002 : EDT 1
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2312 : 2011 : R2020
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2210 : 2002
|
Standard Guide for Processing Cells, Tissues, and Organs for Use in Tissue Engineered Medical Products |
ASTM F 2212 : 2008
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ISO 11137-3:2017
|
Sterilization of health care products — Radiation — Part 3: Guidance on dosimetric aspects of development, validation and routine control |
ISO 11137-2:2013
|
Sterilization of health care products — Radiation — Part 2: Establishing the sterilization dose |
ASTM F 1635 : 1995
|
Standard Test Method for In Vitro Degradation Testing of Poly (L-lactic Acid) Resin and Fabricated Form for Surgical Implants |
ASTM F 1635 : 2004
|
Standard Test Method for in Vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2739 : 2016
|
Standard Guide for Quantifying Cell Viability within Biomaterial Scaffolds |
ASTM F 2382 : 2004
|
Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT) |
ASTM F 2212 : 2002 : R2007
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2212 : 2009
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2211 : 2013
|
Standard Classification for Tissue Engineered Medical Products (TEMPs) |
ISO 22442-3:2007
|
Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents |
ASTM F 2312 : 2010
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2150 : 2007
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2382 : 2017 : EDT 1
|
Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT) |
ASTM F 1635 : 2011
|
Standard Test Method for in vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2211 : 2004
|
Standard Classification for Tissue Engineered Medical Products (TEMPs) (Withdrawn 2013) |
ASTM F 2212 : 2008 : EDT 1
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2312 : 2003
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 1635 : 2004 : REV A
|
Standard Test Method for in Vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2382 : 2018
|
Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT) |